GMP IPO Watch
Bandhan Multi-Factor Fund
Regular Plan · Growth · Bandhan Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +4.70% | +3.52% | 48 of 255 |
| 1M | +1.57% | +1.97% | 148 of 255 |
| 3M | -9.73% | -3.45% | 246 of 252 |
| 6M | -7.89% | +2.92% | 238 of 251 |
| YTD | -14.48% | +1.21% | 246 of 255 |
| 1Y | -8.88% | +1.11% | 203 of 232 |
| INCEPTION | -5.98% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | -1.19% | +9.88% | -13.11% | 49% | 18% |
| 6M | -3.29% | +10.19% | -14.41% | 21% | 6% |
| 1Y | -5.12% | +3.31% | -14.00% | 24% | 7% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity96.20%
- Debt0.00%
- Cash3.54%
- Other0.26%
Market Cap Split
- Large Cap54.81%
- Mid Cap41.39%
- Small Cap0.00%
- Others3.80%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 19.57 | 27.94 |
| P/B | 2.73 | 4.57 |
| Price / Sales | 2.49 | 3.25 |
| Price / Cash Flow | 15.25 | 20.95 |
| Dividend Yield (%) | 1.37 | 1.18 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Triparty Repo TRP_011026 | Reverse Repo / TREPS | 4.03% | — |
| Adani Ports & SEZ | Transport Infrastructure | 2.64% | — |
| Zydus Life Science | Pharmaceuticals & Biotechnology | 2.63% | — |
| Samvardhana Motherson International | Auto Components | 2.57% | — |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.57% | — |
| Coal India | Consumable Fuels | 2.53% | -0.65% |
| Tata Steel | Ferrous Metals | 2.52% | -1.55% |
| Bharat Heavy Electricals | Electrical Equipment | 2.52% | — |
| Bharat Forge | Auto Components | 2.51% | — |
| GMR Airports | Transport Infrastructure | 2.51% | — |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 2.50% | — |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.50% | — |
| Lupin | Pharmaceuticals & Biotechnology | 2.49% | -1.46% |
| Marico | Agricultural Food & other Products | 2.48% | -0.67% |
| JSW Steel | Ferrous Metals | 2.47% | -1.48% |
View all 48 holdings
| NTPC | Power | 2.47% | — |
| Adani Power | Power | 2.47% | — |
| Aditya Birla Capital | Finance | 2.46% | — |
| Oil & Natural Gas Corporation | Oil | 2.46% | — |
| Bharat Electronics | Aerospace & Defense | 2.45% | — |
| State Bank of India | Banks | 2.45% | — |
| Tata Consumer Products | Agricultural Food & other Products | 2.44% | — |
| Bank of Maharashtra | Banks | 2.43% | — |
| IDFC First Bank | Banks | 2.43% | — |
| Nestle | Food Products | 2.42% | -0.89% |
| Nykaa | Retailing | 2.42% | — |
| Yes Bank | Banks | 2.40% | -0.09% |
| Eicher Motors | Automobiles | 2.39% | -1.13% |
| Cummins | Industrial Products | 2.39% | -1.21% |
| Federal Bank | Banks | 2.38% | — |
| Reliance Industries | Petroleum Products | 2.38% | — |
| Hindalco Industries | Non - Ferrous Metals | 2.38% | — |
| Titan | Consumer Durables | 2.37% | -0.98% |
| ABB | Electrical Equipment | 2.37% | — |
| Apollo Hospitals | Equity | 2.35% | — |
| NMDC | Minerals & Mining | 2.31% | — |
| GIC of India | Insurance | 2.21% | — |
| L&T Finance | Finance | 2.18% | — |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 1.88% | — |
| Bank of India | Banks | 1.21% | — |
| AU Small Finance Bank | Banks | 1.19% | — |
| Tata Power | Power | 0.77% | — |
| Laurus Labs | Pharmaceuticals & Biotechnology | 0.70% | — |
| Cash Margin - Derivatives | Net Current Assets | 0.17% | — |
| Cash Margin - CCIL | Net Current Assets | 0.03% | — |
| Cash / Bank Balance | Net Current Assets | 0.00% | — |
| Net Current Assets | Net Current Assets | -0.26% | — |
| Net Receivables/Payables | Net Current Assets | -0.43% | — |
Sector Allocation · Sep 2026
View all 22 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 14.00 | 16.32 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -1.15 | -0.32 | Below Average |
| 3Y | -0.87 | -0.45 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.77 | 0.19 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+59.64% | +47.37% | — | +23.17% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+25.51% | +31.04% | — | +30.18% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+23.57% | — | — | +20.10% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+22.37% | — | — | +11.34% |
|
Mirae Asset Healthcare Fund
Direct Plan · Growth
|
+21.28% | +24.36% | +16.89% | +22.00% |
|
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
|
+20.32% | +18.33% | +12.09% | +15.77% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+20.03% | — | — | +11.89% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+18.89% | +19.86% | +8.28% | +8.45% |
|
HDFC Defence Fund
Regular Plan · IDCW Option
|
+18.80% | +34.56% | — | +36.67% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+18.74% | — | — | +9.24% |
More From Bandhan AMC Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
BANDHAN INNOVATION FUND
Direct Plan · Growth
|
+14.35% | — | — | +20.03% |
|
Bandhan BSE Healthcare Index Fund
Direct Plan · Growth
|
+14.13% | — | — | +8.12% |
|
Bandhan US Treasury Bond 0-1 year specific Debt Passive FOF
Direct Plan · IDCW
|
+10.64% | +8.91% | — | +8.51% |
|
Bandhan Gilt Fund
Direct Plan · Growth
|
+7.31% | +8.25% | +6.45% | +8.58% |
|
Bandhan CRISIL-IBX Financial Services 3-6 Months Debt Index Fund
Direct Plan · Growth
|
+6.77% | — | — | +7.03% |
|
BANDHAN Dynamic Term Fund
Direct Plan · Growth
|
+6.71% | +7.89% | +6.20% | +8.15% |
|
Bandhan Money Market Fund
Direct Plan · Periodic IDCW
|
+6.56% | +7.39% | +6.77% | +4.70% |
|
BANDHAN LIQUID Fund
Direct Plan · Periodic IDCW
|
+6.46% | +6.88% | +6.41% | +1.51% |
|
BANDHAN Arbitrage Fund
Direct Plan · Growth
|
+6.43% | +7.26% | +6.79% | +6.91% |
|
BANDHAN ULTRA SHORT TERM FUND
Direct Plan · Periodic IDCW
|
+6.43% | +7.19% | +6.61% | +4.33% |
About This Scheme
Investment Objective
The scheme seeks to generate medium to long term capital appreciation by investing predominantly in equity and equity related instruments selected based on a multi-factor quantitative model. Disclaimer: There is no assurance or guarantee that the investment objective of the scheme will be realised.
Stated Asset Allocation
Equity & equity related instruments selected based on the Multi-Factor quantitative model theme - 80%-100%, Other equities & equity related securities - 0% - 20% Debt Securities and Money Market Instruments (including Government securities, Securitised debt) - 0% - 20% Units issued by InvITs - 0% - 10%
Exit Load
• If redeemed/switched out on or within 30 days from the date of allotment: 0.50% of the applicable NAV • If redeemed/switched out after 30 days from date of allotment – Nil
Fund Managers
Mr. Rishi Sharma , Mr. Nilesh Saha and Mr. Brijesh Shah
Comanage - Mr. Rishi Sharma (equity portion), Mr. Nilesh Saha (equity portion),Mr. Brijesh Shah (debt portion)
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.